In this episode of the BioVentures podcast, Dr. John Sherrill, Senior Licensing Associate at BioVentures, discusses the basics of technology transfer, intellectual property, and commercialization at UAMS. He explains how inventions—ranging from drugs and devices to software and curricula—can move from the lab to the marketplace, with patents playing a key role in protecting and enabling commercialization. Sherrill emphasizes the importance of early disclosure to avoid losing patent rights and clarifies common misconceptions about the process slowing down research. He highlights that BioVentures works collaboratively with researchers to protect their work and support real-world impact.